Earnings & Reporting

Natural Gas Services Group affirms its dividend, a sign of strength. But what does this payout reveal about its financial health and the booming gas market?

The restaurant group's net income fell sharply as a legal battle over its NYC flagship intensifies, while it places a risky bet on a NJ casino license.

EROAD's new Clarity Edge Multicam brings 360-degree vision and AI fatigue detection to fleets, setting a new standard for safety and operational insight.

With strong Q3 results and key acquisitions, all eyes are on Addus HomeCare's year-end report to see if its growth momentum can be sustained.

A massive new partnership will bring free high school sports video to 72 markets, challenging paywall models and reshaping local media coverage.

For the first time, NCH's heart institute earns national recognition, driven by AI-powered tech and a commitment to world-class care in Southwest Florida.

A new report reveals AI-themed ads failed to connect with viewers, while heartfelt, human-centric stories from brands like the NFL and Budweiser won the night.

Backed by robust earnings and strategic acquisitions, Atmus Filtration's latest dividend signals strong financial health and a commitment to shareholder returns.

The French mining giant is in a full-blown leadership crisis, with its CFO suspended amid an employee-triggered probe just days after its CEO was fired.

Schweiter Technologies will unveil its 2025 results and 2026 strategy on Feb 27, with investors eager for signs of growth and profitability.

As Timbercreek Financial preps its Q4 report, investors eye dividend health and asset quality as key indicators for the broader CRE market's new cycle.

Upexi's new funding bolsters its ambitious Solana treasury, but the deal's terms, including warrant adjustments, raise dilution concerns for investors.

As Dauch Corp, formerly American Axle, prepares its Q4 results, all eyes are on its powertrain-agnostic strategy and the integration of Dowlais Group.

Amid soaring aerospace demand and strong financials, the critical component supplier will outline its tech and market strategy at its March 10 investor day.

In a bold Super Bowl move, Rocket and Redfin are skipping the hard sell to deliver a powerful message on neighborliness. Is this the future of marketing?

With its Q4 results announcement imminent, specialty insurer Trisura is under scrutiny to prove it can sustain growth amid market pressures and investor concerns.

Facing a stock slump and operational woes, Clorox leaders must deliver a convincing turnaround plan at the upcoming CAGNY investor conference.

Viking Therapeutics' upcoming earnings call is about more than just financials. Investors are focused on key pipeline updates for its obesity and MASH drugs.

As Amwell prepares its 2025 results, investors watch to see if its strategic pivot to profitability can redefine the future of digital healthcare.

Silvercrest's latest dividend increase offers a high yield, but a deeper look at its financials reveals a complex picture of strength and sustainability.